Table 1 Patient characteristics
Clinical characteristics | Total (N = 20,552) | S-1 (N = 13,614) | Capecitabine/oxaliplatin (N = 6,938) | P Value |
|---|---|---|---|---|
Age, years, mean (SD) | 61.4 (12.0) | 63.3 (12.1) | 57.6 (11.0) | < 0.0001 |
Age group, years, N (%) | ||||
< 30 | 101 (0.5) | 53 (0.4) | 48 (0.7) | < 0.0001 |
30–39 | 826 (4.0) | 447 (3.3) | 379 (5.5) | |
40–49 | 2,541 (12.4) | 1,417 (10.4) | 1,124 (16.2) | |
50–59 | 5,231 (25.5) | 2,980 (21.9) | 2,251 (32.4) | |
60–69 | 5,866 (28.5) | 3,759 (27.6) | 2,107 (30.4) | |
70–79 | 5,126 (24.9) | 4,166 (30.6) | 960 (13.8) | |
≥ 80 | 861 (4.2) | 792 (5.8) | 69 (1.0) | |
Gender, N (%) | ||||
Male | 14,063 (68.4) | 9,226 (67.8) | 4,837 (69.7) | 0.0047 |
Female | 6,489 (31.6) | 4,388 (32.2) | 2,101 (30.3) | |
Comorbidities, N (%) | ||||
DM | 4,772 (23.2) | 3,360 (24.7) | 1,412 (20.4) | < 0.0001 |
Hypertension | 8,133 (39.6) | 5,803 (42.6) | 2,330 (33.6) | < 0.0001 |
Dyslipidemia | 2,143 (10.4) | 1,561 (11.5) | 582 (8.4) | < 0.0001 |
COPD | 6,712 (32.7) | 4,535 (33.3) | 2,177 (31.4) | 0.0055 |